Russian Pediatric Ophthalmology
https://ruspoj.com/1993-1859
<div class="pop">Peer-review medical journal.<br><strong>Editor-in-Chief</strong>: Lyudmila A. Katargina, MD, Dr. Sci. (Medicine), professor<br><strong>Indexation</strong>: Rusian Science Citation Index, Google Scholar, Ulrich's Periodicals Directory, Dimensions, CrossRef.<br><strong>Open Access & Publication frequency</strong>: Hybrid Access (Open access articles with CC BY-NC-ND license); quarterly issuing; continuously publication online.<br><strong>Peer-Review & APC</strong>: double blind; no obligatory article processing charges.<br><strong>ISSN</strong> 1993-1859 (Print); <strong>ISSN</strong> 2412-432X (Online)</div>
Eco-Vector
ru-RU
Russian Pediatric Ophthalmology
1993-1859
<p>Authors who publish with this journal agree to the following terms:</p> <ol> <li>Authors retain copyright and grant the journal exclusive license to first publication.</li> <li>Authors are able to distribute the manuscript and/or the article in accordance with Self-Archiving policy of the journal (<a href="/1993-1859/about/editorialPolicies#authorSelfArchivePolicy" target="_blank" rel="noopener">see details</a>).</li> <li>The manuscript can be accepted for publication only by decision of the Editor-in-Chief and the Editorial board of the journal in accordance with the Manuscript stelection policy of the journal (<a href="/1993-1859/about/editorialPolicies#peerReviewProcess" target="_blank" rel="noopener">see details</a>).</li> <li>Published Article will be distributed in print and electronic version an will be available under subscription with Delayed Open Access or in Immediate Open Access under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (<a href="https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ru" target="_blank" rel="noopener">CC BY-NC-ND 4.0</a>). The access model depends on the publisher's decision or is determined by a separate Open Access publishing agreement with the authors.</li> </ol> <p>An exclusive license for publication granted by authors allows the publisher to use the article in the following ways:</p> <ul> <li>Reproduction of the Article or its sections or parts, as well as the metadata of the Article in any languages, in any material form, including on paper and electronic media, as a separate work in the journal and/or databases (local or in the Internet) of the publisher and/or other persons, at the discretion of the publisher;</li> <li>Distribution of the Article or its sections or parts, as well as the metadata of the Article in any languages, on any medium as part of the journal and/or databases of the publisher or other persons, at the discretion of the publisher, or as an independent work around the world whether on Open-Access terms or for a fee without remuneration to the Author;</li> <li>Making the Article or any of its sections or parts, as well as the Article’s metadata in any languages, publicly available in such a way that any person can access the Article from any place, including via the Internet, and at any time of their own choosing;</li> <li>Granting permission/s for the use of the Article or its sections or parts, as well as its metadata in any languages, to third parties with notice to the Author made by posting relevant information on the journal’s website, without paying remuneration to the Author;</li> <li>Processing the Article (i.e., editing, correcting, annotating, tagging, translating to any languages, typesetting) and using the revised (translated) Article in the aforementioned ways.</li> </ul> <p>Other rights not directly transferred to the publisher under this License Agreement, including patent rights to any process, method etc., described by the Authors in the manuscript, as well as trademark rights, are reserved for the Authors.</p> <p>All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical <strong>'Russian Pediatric Ophthalmology'</strong>.</p> <p>- <a href="https://ruspoj.com/files/journals/87/doc/Copyrightagreement_final_eng_exclusive_v.2022.09.29.pdf" target="_blank" rel="noopener">DOWNLOAD</a> the print-version of the License Agreement.</p> <div><details open="open"> <summary><strong>READ the details online</strong> (tap to see in details)</summary> <p><strong>Author’s license agreement (public offer) on the publication of an article in a scholarly journal </strong><br /><strong>“Russian Pediatric Ophthalmology”</strong></p> <p>Eco-Vector, represented by its CEO Evgeniy Schepin and acting on the basis of the Charter (hereinafter referred to as the Publisher), on the one hand, offers an indefinite circle of persons (hereinafter referred to as the Author), and on the other hand, hereinafter jointly referred to as the Parties, to execute this agreement (hereinafter referred to as the Agreement) on the publication of scientific article (hereinafter referred to as the Article) in a scholarly journal <strong>“Russian Pediatric Ophthalmology”</strong> (further-the Journal) in accordance with the conditions stated below.</p> <p> </p> <p><strong>I. General Provisions</strong></p> <ol> <li>This Agreement, in accordance with clause 2 of Article 437 of the Civil Code of the Russian Federation, is a public offer (hereinafter referred to as the Offer) requiring full and unconditional acceptance (Acceptance), which, in accordance with Article 438 of the Civil Code of the Russian Federation, means the sending by the Author of his/her materials by way of uploading the same to the online electronic system designed to accept manuscripts for consideration, and subsequently posted in the corresponding section of the Journal’s website on the Internet information and telecommunications network (hereinafter referred to as the Internet).</li> <li>In accordance with the current legislation of the Russian Federation regarding the observance of copyright on electronic information resources, all materials found in a website, including submitted and published in electronic journals, may not be reproduced in whole or in part in any form (electronic or printed) without the prior written permission of the Publisher. Prior permission can be given by publishing an article in the open access with Creative Commons license. The journal requires license users to reference the original source, i.e., the publication, if the Author permits use of the public materials in the context of other documents.</li> </ol> <p> </p> <p><strong>II. Terms used in the Agreement</strong></p> <ol> <li>“Author” refers to an individual (or individuals) whose creative work has led to the creation of the manuscript of a scientific Article, or to a representative of these persons.</li> <li>“Manuscript” is the result of intellectual activity in the form of a scientific work containing text, graphic and numerical data, audiovisual information, program code and other elements submitted by the Author for publication in the Journal; it is also the mean “a draft of an Article submitted by the Author to be published in the Journal”.</li> <li>“Offer” is the current agreement (an offer to the author for the publication of an Article in the Journal).</li> <li>“Publication” is the process of placement of an Article in the Journal.</li> <li>“Article” is the manuscript that has been published in the Journal (after successful selection, editing, type-setting, copyediting, proofreading, translation).</li> <li>“Acceptance of the offer” refers to the full and unconditional acceptance of the offer on the terms specified in paragraph 3 of this agreement (the Author accepts offer by submitting a Manuscript to the Publisher via the online electronic submission system on the Journal’s Internet website).</li> <li>“Journal” is a scientific peer-reviewed periodical registered as a mass media entity in the Roskomnadzor register of the Russian Federation and ISSN-center.</li> <li>“Submission” is an electronic appeal of the Author to the Publisher for the publication of an Article in the Journal by uploading the manuscript and accompanying materials to the online electronic submission system on the Journal’s Internet website).</li> <li>“Publisher” refers to Eco-Vector, which is the Publisher of the journal.</li> <li>Article metadata includes the information that are intended for inclusion in International Scientific Databases and search engines, namely the following: <ul> <li>title of the Article;</li> <li>information about each of the Authors (surname and first name; patronymic; place of work with the postal address indicated, contact information (e-mail));</li> <li>abstract;</li> <li>keywords;</li> <li>thematic rubricator: UDC (Universal Decimal Classification) or other library and bibliographic classification and subject indexes;</li> <li>list of references.</li> </ul> </li> <li>“Editorial board” is the creative team that prepares the journal for publication.</li> <li>“Parties” refers to the Author and the Publisher.</li> <li>“Author Guidelines” are the requirements for Articles published in the Journal, posted in the “For authors” section of the Journal’s Internet website.</li> </ol> <p> </p> <p><strong>III. Subject of the Agreement (Offer)</strong></p> <ol> <li>Under this agreement, the Author grants the Publisher, free of charge for the entire period of validity in accordance with the legislation of the Russian Federation, an exclusive license to use the Article created by the former for publication in the Journal, as well as the rights to use the article in the following ways: <ul> <li>Reproduction of the Article or its sections or parts, as well as the metadata of the Article in any languages, in any material form, including on paper and electronic media, as a separate work in Journals and/or databases (local or in the Internet) of the Publisher and/or other persons, at the discretion of the Publisher;</li> <li>Distribution of the Article or its sections or parts, as well as the metadata of the Article in any languages, on any medium as part of the Journal and/or databases of the Publisher or other persons, at the discretion of the Publisher, or as an independent work around the world whether on Open-Access terms or for a fee without remuneration to the Author;</li> <li>Making the Article or any of its sections or parts, as well as the Article’s metadata in any languages, publicly available in such a way that any person can access the Article from any place, including via the Internet, and at any time of their own choosing;</li> <li>Granting permission/s for the use of the Article or its sections or parts, as well as its metadata in any languages, to third parties with notice to the Author made by posting relevant information on the Journal’s website, without paying remuneration to the Author;</li> <li>Processing the Article (i.e., editing, correcting, annotating, tagging, translating to any languages, typesetting) and using the revised (translated) Article in the aforementioned ways.</li> </ul> </li> <li>Other rights not directly transferred to the Publisher under this Agreement, including patent rights to any process, method etc., described by the Author in the Article, as well as trademark rights, are reserved for the Author.</li> <li>The territory where the rights to the Article are allowed to be used is the whole world.</li> <li>The validity of this Agreement commences only if the manuscript of the Article is accepted for publication in the Journal and only from the moment of sending a notification of acceptance of the Article for publication to the Author from the official e-mail of the Journal.</li> <li>The rights are granted by the Author to the Publisher free of charge; the publication of the Article in the Journal does not entail any financial deductions to the Author.</li> <li>If the Publisher decides to reject the Submission or refuse to publish the Article in the Journal (i.e., retraction of the published Article), this Agreement becomes invalid. The decision to refuse publication will be sent to the Author at the e-mail address specified in the Submission.</li> </ol> <p> </p> <p><strong>IV. Rights and Duties of the Parties</strong></p> <ol> <li>The Author guarantees that: <ul> <li>s/he holds the copyright the exclusive rights to the materials submitted to the Publisher as part of the manuscript of the Article;</li> <li>the rights granted to the Publisher under this agreement have not been previously transferred and will not be transferred to third parties in the future during the duration of the Agreement;</li> <li>the manuscript contains all references to the cited authors and/or publications (materials) provided for under the current copyright legislation;</li> <li>the Author has obtained all the necessary permissions for all information and other materials s/he holds no copyright to and that are used in the manuscript of the Article;</li> <li>the Article manuscript contains only materials permitted to be published in the open press in accordance with the current legislative acts of the Russian Federation, and its publication and distribution will not lead to the disclosure of secret (confidential) information (including state secrets);</li> <li>the Author has informed co-authors about the terms of this Agreement and has received their consent to execute this Agreement under the terms provided for in the Agreement.</li> </ul> </li> <li>The Author carries certain obligations under the terms of the Agreement: <ul> <li>s/he should prepare and submit the manuscript of the Article in accordance with the Author Guidelines posted on the Journal’s website;</li> <li>the Author should not use an electronic copy of the Article for commercial purposes and in other journal publications without the consent of the Publisher;</li> </ul> </li> <li>in the process of preparing a manuscript for publication, the Author is obligated to undertake the following: <ul> <li>make corrections to the text of the manuscript that have been marked by the peer-reviewers and accepted by the editorial board, and/or as necessary, upon the request of the Publisher and the editorial board, finalize the manuscript of the Article;</li> <li>revising and proofreading the manuscript of the Article in accordance with the editorial recommendations;</li> <li>suggest only the minimum of corrections to the type-setted (layout) Article.</li> </ul> </li> <li>The Author has the following rights and duties: <ul> <li>Use preprint or prior-to publication versions of an unpublished Article in the form and content accepted by the Publisher for publication in the Journal. Such prior-to-publish versions can be placed as electronic files on the personal websites of the Author (co-authors) or on the protected external websites of the employers of the Author; however, the Author cannot use the unpublished version(s) for commercial sale or for systematic external distribution by a third party (i.e., post on social media). The author or co-authors must, in turn, carry out certain duties, namely: <ul> <li>include the following warning in the prior-to-publish version: “This is prior-to-publish version of the article accepted for publication in (Journal’s name), © Eco-Vector (year)”;</li> <li>provide the corresponding electronic link to the Publisher’s website at <a href="https://journals.eco-vector.com/">https://journals.eco-vector.com/</a> and/or via the DOI.</li> </ul> </li> <li>Copy or transfer a copy of the published Article in whole or in part to colleagues free of charge for their personal or professional use, for the promotion of academic or scientific research, or for informational purposes of the Author’s employer.</li> <li>Use materials from a published Article in a book written by one of the co-authors.</li> <li>Use figures, tables and text excerpts from the Article for his or her (or co-authors’) own training purposes, or to include them in other published works in printed or electronic format by a third party, or to submit them in electronic format on an internal computer network, or on the public website of the Author (co-authors) or his/her employer.</li> <li>Include the Article in educational collections for use in the classroom, either for free distribution to the Author’s (co-authors’) students or in electronic format on a local server for access by students as part of the training course, as well as for internal training programs at the institution of the Author’s employer.</li> </ul> </li> <li>The Publisher, for its part, is obliged to: <ul> <li>publish the Author’s article in the Journal in printed and electronic form in accordance with the terms of this Agreement;</li> <li>if necessary, as so decided by the Journal’s editorial board, provide the Author with the proofreading of the manuscript and make a reasonable editing;</li> <li>provide to the Author the unlimited access to the final electronic version of the published Article (Version of Record) through the online electronic submission system on the Journal’s Internet website;</li> <li>comply with the Author’s rights as provided for by the current legislation, as well as protect them and take all necessary measures to prevent copyright infringement by third parties.</li> </ul> </li> <li>The Publisher has a right to: <ul> <li>conduct an expert evaluation of the manuscript (peer-reviewing and editorial evaluation) and invite the Author to make the necessary changes (revisions) to the manuscript;</li> <li>provide editing, copyediting, type-setting, proofreading, tagging, indexation and translation of the Article’s manuscript without altering the main content;</li> <li>in any subsequent authorized use by the Author (and/or other persons) of the Journal and/or Article (including any separate part or fragment thereof), require that a link to the Journal, Publisher, Author or other copyright holders, the title of the Article, the Journal’s volume/issue, and the year of publication be specified in the Journal;</li> <li>post preliminary and/or advertising information about the upcoming publication of the Article in the media and other information sources;</li> <li>make changes to the offer in accordance with the procedure established by the offer.</li> </ul> </li> <li>The editorial board of the Journal, headed by the editor-in-chief, has the exclusive rights to select and/or reject materials sent to the Journal editorial office for publications purposes. The manuscript sent by the Author to the Journal editorial office is not subject to return. The editorial board of the Journal does not enter into correspondence about rejection of submissions.</li> <li>In all cases not stipulated and not provided for in this agreement, the parties are obliged to be guided by the relevant current laws of the Russian Federation.</li> </ol> <p> </p> <p><strong>V. Acceptance of the Offer and Execution of the Agreement. Terms of the Agreement</strong></p> <ol> <li>The Author accepts the Offer by submitting the manuscript on the Article to the Publisher through the electronic manuscript submission system on the Journal's Internet website.</li> <li>Acceptance of the offer by the author creates an Agreement in writing (Articles 438 and 1286.1 of the Civil Code of the Russian Federation) on the terms of the offer.</li> <li>This Agreement is valid for the duration of the exclusive rights to the Article.</li> <li>When transferring (alienating) the exclusive right to the Article by the Author to a third party, this Agreement does not terminate.</li> </ol> <p> </p> <p><strong>VI. Procedure for changing and terminating the Agreement</strong></p> <ol> <li>The Publisher has the right to unilaterally change the terms of this Agreement, in advance, at least 10 (ten) calendar days before the entry into force of the intended relevant changes, but with notice to the Author through the Journal’s website or by e-mail to the Author’s e-mail address specified in the Author’s Submission. The changes will take effect from the date specified in the relevant notification.</li> <li>If the Author rejects the changes to the terms of this Agreement, s/he has the right to notify the Publisher by sending a written notification through the online manuscripts submission system, making sure that the same is sent to the official e-mail address of the editorial office.</li> <li>This Agreement may be terminated prematurely, either by agreement of the parties at any time, or on other grounds provided for in this Agreement.</li> <li>The Author has the right to unilaterally withdraw from the execution of this Agreement by sending the Publisher a corresponding notification in writing at least 60 (sixty) calendar days in advance before the expected date of publication of the Article in the Journal.</li> <li>Termination of the Agreement for any reason does not release the parties from liability for any violation of the terms of the Agreement that occurred during the validity period.</li> </ol> <p> </p> <p><strong>VII. Responsibility</strong></p> <ol> <li>The parties are responsible for non-fulfillment or improper fulfillment of their obligations under the Agreement in accordance with the current relevant legislation of the Russian Federation.</li> <li>All information provided by the Author must be reliable. The Author is expected to provide accurate and complete the information to the Publisher. When using false information received from the Author, the Publisher is not responsible for the negative consequences caused by his actions on the basis of the false information provided.</li> <li>With regard to the content of the Article, the Author is solely responsible for compliance with the requirements of the laws of the Russian Federation pertaining to advertising, copyright and related rights’ protection, protection of trademarks and service marks, and the protection of consumer rights.</li> <li>The Publisher does not bear any responsibility under the agreement: <ul> <li>for any actions that are a direct or indirect result of Author’s illegal actions;</li> <li>for any loss incurred by the Author, regardless of whether the Publisher could have foreseen the possibility of such losses or not.</li> </ul> </li> <li>The Publisher is released from liability for violation of the terms of the Agreement if such violation is caused by force majeure, including actions of state authorities (including the adoption of legal acts), fire, flood, earthquake, other natural disasters, lack of electricity and/or computer network failures, strikes, civil unrest, riots, etc.</li> </ol> <p> </p> <p><strong>VIII. Dispute resolution</strong></p> <ol> <li>Disputes and disagreements will be resolved by the parties through negotiations, and in case of failure to reach an Agreement they will strive to seek resolution in accordance with the current legislation of the Russian Federation.</li> <li>If there are unresolved disagreements, the parties agree to resolve the disputes in court at the jurisdiction covered by the Publisher’s location in accordance with the current legislation of the Russian Federation.</li> </ol> <p> </p> <p><strong>IX. Miscellaneous</strong></p> <ol> <li>All notifications, messages, requests, etc. (with the exception of documents that must be sent as originals in accordance with the laws of the Russian Federation) are considered received by the Author if they were transmitted (sent) by the Publisher through the Journal’s website (including by publication), fax, e-mail based on the address specified in the Submission, and other communication channels. The parties recognize the legal force of notifications, messages, requests, etc., transmitted (sent) by the above methods.</li> <li>In the event of claims against the Publisher related to the violation of the exclusive copyright and other intellectual property rights of third parties when creating an article or in connection with the execution of this Agreement by the Author, as well as in connection with the use of the Article by the Publisher in accordance with the Agreement, the author undertakes: <ul> <li>To immediately take measures to resolve disputes with third parties soon after receiving Publisher’s notification, and if necessary, enter into legal proceedings on the Publisher’s side and take all appropriate actions needed to exclude the Publisher from the list of defendants;</li> <li>To reimburse the publisher for the legal costs incurred and expenses and losses caused by the application of measures to secure the claim and execute a court decision, and the money paid to a third party for the violation of exclusive copyright and other intellectual property rights, as well as other losses incurred by the Publisher in connection with the Author’s non-compliance with the guarantees provided by them under this Agreement.</li> </ul> </li> </ol> <p> </p> <p><strong>X. Legal address and details of the Publisher</strong></p> <ul> <li>Eco-Vector</li> <li>Address: 191186, St. Petersburg, Aptekarsky Pereulok, 3 letter A, room 1N</li> <li>TIN: 7806423692; KPP: 784101001; OGRN: 1099847039907.</li> </ul> </details></div>
-
Results of surgical treatment of children with lens subluxation
https://ruspoj.com/1993-1859/article/view/568550
<p><strong>AIM</strong><em>: </em>To assess the effectiveness of the surgical treatment of patients with lens subluxation, who were under 18 years old.</p> <p><strong>MATERIAL AND METHODS</strong><em>: </em>This study presented an analysis of the results of surgical treatment of eight patients with lens subluxation. The operations were performed in the Department of Ophthalmology of the State Healthcare Institution of Healthcare MCMC “Bonum,” carried out in 2020–2022. The inclusion criteria were as follows: age under 18 years, Marfan-like phenotype, stages 2–4 subluxation, absence of retinal changes and other eye pathologies, and surgical treatment performed in 2020–2022. The mean age at the detection of lens subluxation was 3.9±2.0 years, and the age during primary surgery was 5.4±1.9 years. All patients underwent phacoaspiration of the subluxated lens with anterior vitrectomy, simultaneous implantation, and sclerocorneal fixation of the intraocular lens by the same surgeon using the same equipment and consumables.</p> <p><strong>RESULTS</strong><em>: </em>The ophthalmological status was mainly assessed, and a statistical difference (<em>p</em> <0.05) was found between pre- and postoperative indicators. Before surgery, the maximum corrected visual acuity was 0.15±0.12 (min 0.02; max 0.5); spherical equivalent, 6.8±4.7 (min -15; max +16); total astigmatism value, 3.25±1.15 (min, 1; max, 6.5); and corneal astigmatism, 2.4±0.9 (min, 1; max, 3.9). After the surgical treatment, the maximum corrected visual acuity was 0.53±0.31 (min, 0.05; max, 0.9); spherical equivalent, −0.6±1.71 D (min −3.5; max +3); total astigmatism, -1.63±0.75 D (min, -0.25; max, −2.75); corneal astigmatism, 2.4±0.7 D (min 1; max 3.5). All operations were performed without complications. The postoperative period in patients was regarded as unreactive.</p> <p><strong>CONCLUSION</strong><em>: </em>The results show that sclerocorneal fixation allows for reliable and safe fixation of intraocular lenses without capsule support. A statistically significant increase in visual acuity was found after surgery; however, for optimal functional results in the postoperative period, refractive errors and pleoptic treatment must be controlled.</p>
Mihail A. Karyakin
Elena A. Stepanova
Tatiana A. Zaharova
Stanislav V. Khlopotov
Ivan Yu. Baksheev
Copyright (c) 2023 Eco-Vector
https://eco-vector.com/for_authors.php#07
2023-12-16
2023-12-16
18 4
177
183
10.17816/rpoj568550
-
Clinical features and results of surgical treatment of congenital corneal opacities in infants and children under 3 years of age
https://ruspoj.com/1993-1859/article/view/569148
<p>Congenital corneal opacities (CCO) are rare eye anomalies of various etiological causes. Given the heterogeneity of the clinical and morphological manifestations of CCO, its functional disorders are of the same type and significant, leading to visual disability. This anomaly occurs in 6 per 100,000 newborns.</p> <p><strong>AIM</strong><em>:</em> To study the clinical and anatomical features and treatment results of CCO in children aged under 3 years old, who were treated in the Department of Eye Pathology in Children of Helmholtz National Medical Research Center of Eye Diseases for the period from January 1, 2010, to December 31, 2022 (12 years).</p> <p><strong>MATERIAL AND METHODS</strong><em>: </em>The clinical and anatomical features and results of surgical treatment of 142 patients (172 eyes) with CCO aged 0–3 years were analyzed in the period from January 1, 2010, to December 31, 2022. According to the clinical picture, all CCOs were classified as congenital glaucoma, sclerocornea, Peters anomaly, anterior staphyloma, endothelial corneal dystrophy, dermoid, and Axenfeld–Rieger syndrome, and were idiopathic. Surgical methods included end-to-end keratoplasty, layered keratoplasty, limbokeratoplasty, and end-to-end reconstructive keratoplasty, including synechial excision, cataract removal, pupil formation, and anterior vitrectomy. The treatment results were evaluated based on the biological and functional results. The biological results of the operation (graft engraftment) were evaluated in the Kaplan–Meier model.</p> <p><strong>RESULTS</strong><em>:</em> Congenital glaucoma dominates among clinical diagnoses of CCO (40% of all cases), followed by Peters anomaly, sclerocornea, congenital hereditary endothelial corneal dystrophy, other hereditary corneal dystrophies and anterior staphyloma, Axenfeld–Rieger syndrome, and corneal dermoid. In 5 (3%) cases, the CCO was defined as idiopathic. Surgical treatment was performed on 78 (86 eyes) out of 142 (54.9%) patients. The 1-year survival rate following transplants in patients with high blood pressure was 75%; with Peters anomaly, 67%; and with sclerocornea, 54%, and the 2-year survival rates were 70%, 63%, and 36%, respectively. The 1 and 2 years urvival rates following transplants in patients with congenital endothelial hereditary dystrophy were 88 and 82%, respectively.</p> <p><strong>CONCLUSION</strong><em>:</em> The results show that CCO manifest heterogeneously in children aged under 3 years old. Careful anamnesis collection, thorough clinical examination, and additional studies such as UBM are crucial in obtaining accurate diagnosis and classification of CCO and provide recommendations on treatment strategies.</p>
Alla V. Pleskova
Anna Yu. Panova
Copyright (c) 2023 Eco-Vector
https://creativecommons.org/licenses/by-nd/4.0/
2023-12-16
2023-12-16
18 4
185
190
10.17816/rpoj569148
-
Аnnual results of the use of spectacle lenses with embedded rings of high-spherical microlenses Stellest™ for the control of myopia
https://ruspoj.com/1993-1859/article/view/567973
<p><strong>AIM</strong><em>: </em>To evaluate the effect of continuous wearing of Stellest™ spectacle lenses on refractive dynamics, accommodation, and binocular interaction after 6 months and 1 year.</p> <p><strong>MATERIAL AND METHODS</strong><em>:</em> Children aged 8–13 years who had mild-to-moderate myopia were included. Stellest™ spectacle lenses were prescribed to 35 children with myopia (3.15±0.19 D on average). The control group consisted of 32 children with myopia (2.68±0.18 D on average) using single-vision correction. Refraction, axial length of the eye, accommodation, and binocular interaction were evaluated.</p> <p><strong>RESULTS</strong><em>:</em><strong> </strong>After 1 year, the average increase in refraction in the Stellest™ group was 0.19±0.07 D. A decrease in the annual progression gradient (APG) was observed in 82.4% of cases and averaged 0.72±0.1 D. The axial length of the eye increased by an average of 0.08±0.02 mm. In the control group, after 1 year of observation, the average increase in refraction was 0.6±0.07 D. A decrease in APG was observed in 51.6% of the cases and averaged 0.26±0.12 D. The axial length of the eye increased by an average of 0.26±0.03 mm. After 1 year, the increase in refraction and growth of the axial length of the eye in the Stellest ™ group was less than that in the control group by 68.3% and 69.2%, respectively. In the Stellest™ group, positive relative accommodation (PRA) increased after 1 year by 1.06±0.14 D and that in the control group by 0.6±0.16 D. The difference was significant (<em>p </em><0.02). No differences were found between the groups in terms of objective indicators of accommodation. The stabilization effect in Stellest™ spectacle lenses was the least pronounced with esophoria.</p> <p><strong>CONCLUSION</strong><em>:<strong> </strong></em>The use of Stellest™ spectacle lenses slows down the progression of myopia in children and reduces APG by more than two times. A significant increase in PRA was found in children using Stellest™ spectacle lenses for 1 year compared with children using single-vision correction.</p>
Olga V. Proskurina
Elena P. Tarutta
Natalia A. Tarasova
Sergey V. Milash
Sona G. Arutyunyan
Gajane A. Markosyan
Copyright (c) 2023 Eco-Vector
https://creativecommons.org/licenses/by-nd/4.0/
2023-12-16
2023-12-16
18 4
191
203
10.17816/rpoj567973
-
Congenital cataract associated with COVID-19 infection
https://ruspoj.com/1993-1859/article/view/595867
<p><strong>AIM</strong><em>:</em> To describe cases of COVID-19-induced congenital pathology of the lens and eye in children.</p> <p><strong>MATERIALS AND METHODS</strong><em>:</em> Nine children (9 eyes) aged 3–6 months with congenital cataract (СC), whose mothers had COVID-19 during pregnancy, were examined.</p> <p><strong>RESULTS</strong><em>: </em>All children had unilateral CC, with heterogeneous turbidity. Changes in the shape, volume, and structure of the capsule sac were often combined with microphthalmia (66.7%) and primary persistent vitreous body syndrome (PPGST) (88.9%).</p> <p><strong>CONCLUSION</strong><em>: </em>The results revealed the possibility of the unilateral development congenital pathology of the lens with the presence of concomitant pathology: microphthalmos, PPGST syndrome in children born to mothers who had SARS-CoV-2 infection during pregnancy. Given the risk of transplacental transmission of the coronavirus from a pregnant woman to a fetus with СC development, these children need a more detailed examination in the first month of life for timely detection of pathology and provision of treatment. Surgical treatment of this pathology often requires a nonstandard individual approach to each stage of the operation and management of the postoperative period.</p>
Tatyana B. Kruglova
Naira S. Egyan
Elena N. Demchenko
Copyright (c) 2023 Eco-Vector
https://creativecommons.org/licenses/by-nd/4.0/
2023-12-16
2023-12-16
18 4
205
212
10.17816/rpoj595867
-
Аcute sinusitis as a cause of orbit phegmon in a newborn child
https://ruspoj.com/1993-1859/article/view/569012
<p>Orbital complications of varying severity caused by acute sinusitis are relatively common in pediatric practice. These complications develop depending on the anatomical features of the paranasal sinuses and eye sockets in children and immune system impairment.</p> <p><strong>AIM<em>:</em></strong> To present a clinical case of orbital phlegmon in a newborn child.</p> <p><strong>RESULTS<em>:</em></strong> A 17-day-old female infant was admitted to the Infectious Diseases Department of the Altai Regional Center for Maternal and Childhood Protection. After self-treatment, her health status did not improve; thus, she was hospitalized. After additional instrumental methods of research, the following diagnosis was made: рhlegmon of the left orbit, subperiosteal abscess on the left, and ethmoiditis with destruction on the left. A consultation of specialists (an ophthalmologist, otorhinolaryngologist, and neonatologist) determined the further management approach.</p> <p><strong>CONCLUSION<em>:</em></strong> Orbital complications in pediatric practice require an immediate assessment of the clinical condition by an otorhinolaryngologist and an ophthalmologist. The clinical case presented focuses on the need for an interdisciplinary approach and hospitalization in the initial disease stages to provide therapy because the infection may spread to the intracranial region.</p>
Svetlana I. Makogon
Vladimir I. Lebedev
Copyright (c) 2023 Eco-Vector
https://eco-vector.com/for_authors.php#07
2023-12-16
2023-12-16
18 4
213
219
10.17816/rpoj569012
-
Clinical case of bilateral rapidly progressive osteoma of the choroid
https://ruspoj.com/1993-1859/article/view/364508
<p>Choroidal osteoma is a benign neoplasm characterized by the appearance of mature bone tissues at the level of the choroid and unilateral development. This study highlights a clinical case of bilateral rapidly progressing osteoma of the choroid in a child, which was complicated by tumor decalcification and choroidal neovascularization. A 14-year-old male teen has been under observation in the S. Fyodorov Eye Microsurgery Federal State Institution, Saint-Petersburg branch since 2019, for bilateral choroidal osteoma. At the initial visit, a yellow-orange lesion with clear boundaries was noted in the left eye, localized at the level of the choroid and parapapillary, and had a trabecular bone structure. Based on the clinical picture and data from instrumental studies (ultrasound and optical coherence tomography), he was diagnosed with choroidal osteoma. During observation, a similar lesion appeared in the right eye, and its relatively rapid growth was observed in both eyes. Owing to the absence of zones of decalcification and neovascularization, further follow-up was initiated. However, in the presence of zones of decalcification of the bone tissue and newly formed vessels of the choroid, a threefold intravitreal injection of an angiogenesis inhibitor was performed. Consequently, regression of choroidal neovascularization was observed. Speculatively, the main reason for the atypical disease course in this teenager is the specificity of bone tissue development in childhood and adolescence.</p>
Irina E. Panova
Kristina K. Shefer
Alexander I. Shilov
Copyright (c) 2023 Eco-Vector
https://eco-vector.com/for_authors.php#07
2023-12-16
2023-12-16
18 4
221
230
10.17816/rpoj364508